HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Supriya Pokkali Selected Research

Aerosols

1/2018Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
1/2016Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Supriya Pokkali Research Topics

Disease

11Tuberculosis (Tuberculoses)
01/2020 - 04/2009
9Infections
01/2020 - 03/2008
3Neoplasms (Cancer)
12/2023 - 06/2011
3Pulmonary Tuberculosis
01/2020 - 02/2009
2Virus Diseases (Viral Diseases)
12/2023 - 06/2011
2Granuloma
01/2018 - 01/2015
2Inflammation (Inflammations)
01/2017 - 10/2014
2Myositis (Idiopathic Inflammatory Myopathies)
01/2017 - 10/2014
2Meningeal Tuberculosis (Tuberculous Meningitis)
12/2016 - 01/2013
2Coinfection
10/2014 - 06/2011
2Pleural Tuberculosis
04/2009 - 03/2008
1Calcinosis
10/2015
1Bites and Stings (Sting)
04/2015
1Pneumonia (Pneumonitis)
10/2014
1Klebsiella Infections (Klebsiella Infection)
10/2014
1Sepsis (Septicemia)
06/2011
1Pleurisy (Pleuritis)
12/2008

Drug/Important Bio-Agent (IBA)

4ChemokinesIBA
06/2011 - 03/2008
3VaccinesIBA
01/2020 - 01/2013
3Matrix Metalloproteinases (MMPs)IBA
01/2019 - 01/2016
3Chemokine ReceptorsIBA
04/2009 - 03/2008
3CytokinesIBA
02/2009 - 03/2008
2AerosolsIBA
01/2018 - 01/2016
2InterferonsIBA
04/2015 - 12/2008
1Toll-Like Receptor AgonistsIBA
12/2023
1BCG VaccineFDA Link
01/2020
1Matrix Metalloproteinase InhibitorsIBA
01/2019
1tasquinimodIBA
01/2019
1PyrazinamideFDA LinkGeneric
01/2018
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2018
1Etanercept (Enbrel)FDA Link
01/2018
1AntibodiesIBA
01/2018
1ZincIBA
01/2018
1Peptide Hydrolases (Proteases)FDA Link
01/2018
1Rifampin (Rifampicin)FDA LinkGeneric
01/2018
1denileukin diftitox (Ontak)FDA Link
01/2017
1FluorineIBA
01/2017
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2016
1FluoridesIBA
10/2015
1SodiumIBA
10/2015
1cyclic diadenosine phosphateIBA
04/2015
1Interferon Regulatory FactorsIBA
04/2015
1N,N- diethyl- 2- (2- (4- methoxyphenyl)- 5,7- dimethyl- pyrazolo(1,5- a)pyrimidin- 3- yl)- acetamideIBA
01/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
12-deoxy-2-fluorosorbitolIBA
10/2014
1Immune Sera (Antisera)IBA
01/2013
1Virulence Factors (Pathogenicity Factors)IBA
01/2013
1Protein Subunits (Protein Subunit)IBA
01/2013
1LipopolysaccharidesIBA
06/2011
1HLA-DR Antigens (HLA-DR)IBA
04/2009
1ImmunosorbentsIBA
02/2009
1EnzymesIBA
02/2009
1Fas Ligand Protein (Fas Ligand)IBA
12/2008

Therapy/Procedure

2Immunotherapy
12/2023 - 01/2017
2Therapeutics
01/2017 - 12/2016
1Intravenous Administration
01/2020
1Aftercare (After-Treatment)
01/2016
1Drug Therapy (Chemotherapy)
10/2014